Loading chart…
PRE-MARKET
Krebs Biochemicals & Industries Limited engages in the manufacture of active pharmaceutical ingredients in India. It offers androstenedione for steroid intermediate indications, as well as lovastatin and simvastatin for anti-cholesterol applications. The company also develops amlodipine and telmisartan for anti-hypertension; cetirizine for antihistamine; orlistat for anti-obesity; serratiopeptidase for anti-inflammatory; and phenylephrine for cold and cough.
Krebs Biochemicals & Industries Limited (KREBSBIO) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The KREBSBIO share price is ₹59.62 (+3.69% today), with a market capitalisation of ₹1B. MarketRipple tracks the KREBSBIO investment thesis, the ripple-chain impact of market events on Krebs Biochemicals & Industries Limited, and the Healthcare sector outlook.
Open
₹58.60
High
₹61.99
Low
₹58.06
Prev. Close
₹57.50
52W High
₹76.85
52W Low
₹38.33
Day range
₹58.06–₹61.99
52-week range
₹38.33–₹76.85
Volume
16K
P/E
—
ROE
10.4%
D/E
-1.66
Margin
-49.7%
Krebs Biochemicals & Industries Limited (NSE: KREBSBIO) is currently trading at ₹59.62 (+3.69%).
Krebs Biochemicals & Industries Limited's market capitalization is ₹1B.
Krebs Biochemicals & Industries Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).